Skip to headlines

SCIENCE

Cancer-fighting antibodies with a one-two punch take aim at tumours

NatureMonday, August 3, 2026 at 12:00 AM

RedScroll Brief

Nature, Published online: 03 August 2026; doi:10. 1038/d41586-026-02398-4 Bispecific antibodies, which bind to two targets, are sweeping into the clinic and are prompting even more elaborate versions.

RedScroll Signal

Impact
High
Category
Science
Market relevance
None
Why it matters
Scientific signal separates durable discovery from noise — and often foreshadows policy and product. Nature, Published online: 03 August 2026; doi:10. 1038/d41586-026-02398-4 Bispecific antibodies, which bind to two targets, are sweeping into the clinic and are prompting even more elaborate versions.

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

Nature, Published online: 03 August 2026; doi:10. 1038/d41586-026-02398-4 Bispecific antibodies, which bind to two targets, are sweeping into the clinic and are prompting even more elaborate versions.

Why it matters

Scientific signal separates durable discovery from noise — and often foreshadows policy and product.

Background

Nature reported on this under science. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

  1. Nature published: Cancer-fighting antibodies with a one-two punch take aim at tumours

  2. Story is in today’s RedScroll edition. Follow the original source for updates.

More on

Related stories

Source

Nature

Original reporting by Nature. RedScroll provides an extractive briefing only.